Therapeutic potential of 6BIO and DKK1-LRP6 inhibitor in Wnt/β-catenin pathway modulation for amyloid-β-induced Alzheimer's disease model
Journal of Alzheimer’s Disease · 2025-09 · 107 (2) · 857-878
DOI: 10.1177/13872877251362787 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025-09. Verfasst von Manisha Prajapat und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Low Density Lipoprotein Receptor-Related Protein-6, Wnt Signaling Pathway, Intercellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 89 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
The Wnt/β-catenin signaling pathway plays a crucial role in central nervous system development, with emerging evidence linking its dysregulation to the progression of Alzheimer's disease (AD).
Objective
This study investigates the activation of Wnt signaling by targeting GSK3β and the DKK1/LRP6 interaction using a combination of 6BIO (6Bromoindirubin-3-oxime) and a novel gallocyanine derivative (8e) modulator.
Methods
We identified the interaction energy scores of both modulators with target proteins through an in-silico approach. Furthermore, the effects of 6BIO (10 µM) and 8e (20 µM) were assessed in SH-SY5Y cells treated with Aβ 1–42 (20 µM). The efficacy of these modulators was also evaluated in male Wistar rats through dose-ranging studies. An Alzheimer's disease model was established via intracerebroventricular injection of Aβ 1–42 , followed by treatment with 6BIO (23.8 µg/kg/day, i.p.) and 8e (4.2 mg/kg/day, i.p.).
Results
Both modulators demonstrated favorable binding energy scores and dynamic simulation results against the targeted proteins. In Aβ 1–42 -treated SHSY5Y cells, the combination of 6BIO and 8e significantly reduced reactive oxygen species production and apoptotic activity while modulating protein expression. In vivo study, rats treated with combination of 6BIO and 8e modulators exhibited improved neurobehavioral activity compared to AD model rats, along with altered expression of DKK1, β-catenin, p-tau, and pGSK3β. Additionally, decreased oxidative stress and apoptosis markers.
Conclusions
These findings suggest that the combined targeting of GSK3β and LRP6 represents a promising therapeutic strategy for AD. The combination of 6BIO and 8e shows potential as a novel modulator and warrants further investigation in clinical trials to assess its therapeutic efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
- Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Guwahati, India.
- Department of Biochemistry, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
- Kurukshetra University, Kurukshetra, India.
- Department of Anesthesia, Stanford University, Stanford, CA, USA.
ORCID-Profile: Gajendra Choudhary, Bikash Medhi
Zitieren
APA
Prajapat, M., Sarma, P., Kaur, G., Choudhary, G., Jain, S., Kamal, R., Bains, O., Sangwan, N., Prakash, A., & Medhi, B. (2025). Therapeutic potential of 6BIO and DKK1-LRP6 inhibitor in Wnt/β-catenin pathway modulation for amyloid-β-induced Alzheimer's disease model. Journal of Alzheimer’s Disease, 107(2), 857-878. https://doi.org/10.1177/13872877251362787
Vancouver
Prajapat M, Sarma P, Kaur G, Choudhary G, Jain S, Kamal R, et al. Therapeutic potential of 6BIO and DKK1-LRP6 inhibitor in Wnt/β-catenin pathway modulation for amyloid-β-induced Alzheimer's disease model. Journal of Alzheimer’s Disease. 2025;107(2):857-878. doi:10.1177/13872877251362787
BibTeX
@article{Prajapat2025,
author = {Prajapat, Manisha and Sarma, Phulen and Kaur, Gurjeet and Choudhary, Gajendra and Jain, Shaveta and Kamal, Raj and Bains, Omkar and Sangwan, Namrata and Prakash, Ajay and Medhi, Bikash},
title = {Therapeutic potential of 6BIO and DKK1-LRP6 inhibitor in Wnt/β-catenin pathway modulation for amyloid-β-induced Alzheimer's disease model},
journal = {Journal of Alzheimer’s Disease},
year = {2025},
volume = {107},
number = {2},
pages = {857--878},
doi = {10.1177/13872877251362787}
}
EUVIMED